多期DCE-MRI影像组学列线图用于浸润性乳腺癌淋巴血管侵犯的术前预测
该回顾性研究纳入173例乳腺癌患者,基于多期DCE-MRI影像组学特征联合临床病理独立危险因素构建术前列线图预测淋巴血管侵犯。训练集列线图AUC为0.876,验证集为0.832,均高于临床模型和多期影像组学模型,终末期特征贡献最大。
要点
- 终末期DCE-MRI影像组学特征对淋巴血管侵犯的预测价值高于早期和峰值期。
- 多期模型9个特征中6个来自终末期,提示终末期信息贡献最大。
- 联合腋窝淋巴结状态、Ki-67与影像组学评分的列线图预测效能最优。
核心结论
- 基于DCE-MRI的影像组学模型可用于预测浸润性乳腺癌淋巴血管侵犯状态,终末期特征提供更有价值的信息,术前列线图提升了识别LVI的诊断能力,可能有助于临床医生制定个体化治疗决策。
研究设计与样本
- 回顾性分析173例乳腺癌患者的术前临床、病理及DCE-MRI数据,按7:3随机分为训练集121例和验证集52例;采用单因素及多因素logistic回归筛选临床病理独立危险因素(多因素P<0.05)构建临床模型,并建立早期、峰值期、终末期单期模型及整合多期影像组学特征的多期模型,再将多期模型rad-score与临床病理独立危险因素联合构建术前列线图。
关键影像表现/征象
- 多期模型共9个与LVI相关的特征,其中1个来自早期、2个来自峰值期、6个来自终末期。
- 终末期提取的影像特征预测性能明显优于其他单期特征。
诊断标准与关键数值
- 训练集AUC:临床模型0.734 vs 多期模型0.840 vs 列线图0.876。
- 验证集AUC:临床模型0.765 vs 多期模型0.753 vs 列线图0.832。
- 腋窝淋巴结状态和Ki-67被确定为临床病理独立预测因子并用于构建临床模型。
临床应用与阅片要点
- 列线图结合多期影像组学rad-score与腋窝淋巴结状态、Ki-67,可用于术前评估LVI状态。
- 终末期DCE-MRI特征应纳入影像组学分析以提高LVI预测信息量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) radiomics had been used to evaluate lymphovascular invasion (LVI) in patients with breast cancer. However, no studies had explored the associations between features from delayed phase as well as multiphases DCE-MRI and the LVI status. Thus, we aimed to develop an efficient nomogram based on multiphases DCE-MRI to predict the LVI status in invasive (IBC) breast cancer patients.
MATERIALS AND METHODS: A retrospective analysis was conducted on preoperative clinical, pathological, and DCE-MRI data of 173 breast cancer patients. All patients were randomly assigned into training set (n=121) and validation set (n=52) in 7:3 ratio. The clinical, pathologic, and conventional MRI characteristics were then subjected to univariate and multivariate logistic regression analysis, and the clinical risk factors with P < 0.05 in the multivariate logistic regression were used to build clinical models. Different single-phase models (early phase, peak phase, and terminal phase), as well as a multiphases model integrating radiomics features from multiple phases, were established. Furthermore, a preoperative radiomics nomogram model was constructed by combining the rad-score of the multiphases model with clinicopathologic independent risk factors. Finally, the performance of the multiphases model, clinical model, and rad-score was compared using receiver operating characteristic (ROC) curves, area under the curve (AUC) values, and decision curve analysis (DCA). The clinical utility of the rad-score was evaluated using calibration curves, and Delong test was used to compare the differences in AUC values among the different models.
RESULTS: The axillary lymph nodes (ALN) status and Ki-67 had been identified as clinicopathologic independent predictors and a clinical model had been constructed. Image features that were extracted from the terminal phase of the DCE-MRI exhibited notably superior predictive performances compared to features from the other single phases. Particularly, in the multiphases model, terminal phase features were identified as potentially providing more predictive information. Among the nine features that were found to be associated with LVI in the multiphase model, one was derived from the early phase, two from the peak phase, and six from the terminal phase, indicating that terminal phase features contributed significantly more information towards predicting LVI. Evaluation of the nomogram performance revealed promising results in both the training set (AUCs: clinical model vs. multiphase model vs. nomogram=0.734 vs. 0.840 vs. 0.876) and the validation set (AUCs: clinical model vs. multiphase model vs. nomogram=0.765 vs. 0.753 vs. 0.832).
CONCLUSION: The DCE-MRI-based radiomics model demonstrated utility in predicting LVI status, features of the terminal phase offered more valuable information particularly. The preoperative radiomics nomogram enhanced the diagnostic capability of identifying LVI status in IBC patients, and might aid clinicians in making personalized treatment decisions.
引用
- Ma Q, Lu X, Chen Q, et al. Multiphases DCE-MRI Radiomics Nomogram for Preoperative Prediction of Lymphovascular Invasion in Invasive Breast Cancer. Acad Radiol. 2024. PMID: 39107190. doi:10.1016/j.acra.2024.06.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。